Aristotle University Of Thessaloniki (AUTH)
Διερεύνηση αντοχής των σταφυλοκόκκων σε οξαζολιδόνες και στρεπτογραμμίνες με φαινοτυπικές και μοριακές μεθόδους
Abstract
dc:descriptionStaphylococcus is one of the most important pathogens implicated in infections. With the emergence and dissemination of MRSA in hospitalized patients and in the community, therapy for staphylococcal infections has become increasingly difficult due to their resistance to antibiotics. Glycopeptides have been the drugs of choice for treating multiresistant staphylococci. However, with the emergence of intermediate susceptibility to glycopeptides, other treatment alternatives such as linezolid and quinupristin/dalfopristin have become important. Linezolid is the first member of the oxazolidone class of antimicrobials and quinupristin/dalfopristin is a combination of streptogramin B and A compounds. The aim of this thesis was to investigate the in vitro susceptibility of staphylococci against linezolid and quinupristin/dalfopristin and to detect the molecular basis of the responsible resistance mechanisms. A total of 475 clinical isolates, comprising 140 S. aureus and 335 CoNS were collected from AHEPA Hospital, between 2005-2007. Each isolate was identified at species level by Gram stain, catalase and coagulase tests and by Vitek 2 system. Methicillin resistance of isolated staphylococci was detected by the presence of PBP2a protein with Slidex MRSA test (Biomerieux). Of the 140 S. aureus 50 (36%) strains were methicillin-resistant (MRSA) and of the 335 CoNS isolates 255 (76%) were methicillin resistant. Susceptibility testing for various antimicrobial agents was performed by broth microdilution method using the automated system Vitek2. The MICs of linezolid and quinipristin/dalfopristin were determined for the clinical isolates by Etest according to manufacturer’s instructions. The classification of isolates as susceptible or resistant was carried out according to the CLSI criteria. The susceptibility test results for staphylococci showed that linezolid remains active against this microorganism. Linezolid inhibited all isolates at concentrations between 0.19-3mg/l. The modal linezolid MIC for S. aureus and CoNS was 1.18mg/l and 0.87mg/l respectively. The linezolid MIC₅₀ and MIC₉₀ values for S. aureus and CoNS were 0.75 mg/I, 1mg/l and 0.5mg/l, 0.80 mg/I respectively. Of 475 strains 12 S. aureus and 13 CoNS were found to express low level resistance to quinupristin/dalfopristin (MIC=1-4mg/l) and 3 isolates (1 S. epidermidis, 2 S. cohnii) were resistant (MIC>4mg/l). Isolates with MICs≥1mg/l were tested for the presence of genes encoding resistance to streptogramin A [vat(A,B,C), vga(A,B)] and streptogramin B[vgb(A,B), erm(A,B,C), msr(A,B)] by PCR. PCR detected the following resistance genes: 11 CoNS isolates carried the vgaA gene, 12 CoNS isolates carried the ermA gene, 7 S. aureus isolates carried the ermC gene and 2 S. aureus isolates carried the ermA gene. The 11 vgaA positive isolates were identified to the species level by a molecular method based on the tuf gene followed by sequencing analysis. Molecular identification showed the same results for 10 out of 11 isolates, except for one strain which initially was identified as S. epidermidis with Vitek2 but finally turned to be S. haemolyticus. Clonality of resistant isolates (7 S. epidermidis, 4 S. haemolyticus, 2 S. cohnii) was assessed by pulsed-field-gel-electrophoresis (PFGE) after digestion of chromosomal DNA with Smal. PFGE results showed that all S. epidermidis isolates were clonally related, belonging to the same clone. Each isolate of S. haemolyticus and S. cohnii expressed a different clone. In the present study all staphylococcal isolates were susceptible to linezolid which indicates that this antimicrobial agent is a promising therapeutic option. The surveillance for the detection of possible resistant strains needs to be continual with the use of the appropriate methods. The emergence of CoNS isolates resistant to quinipristin/dalfopristin should be a matter of special concern. Our study pointed out that the implementation of molecular methods is necessary for the documentation of resistance to Q/D, especially in cases of low level resistance. This thesis aspires to serve as a basis for the surveillance of staphylococci resistance against linezolid and quinipristin/dalfopristin antibiotics. Prudent use of these drugs is indispensable in an era of rapidly growing resistance.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tatsiopoulos, Apostolos
- Τατσιόπουλος, Απόστολος
Subjects
dc:subject × 18- Σταφυλόκοκκοι
- Λινεζολίδη
- Κινοπριστίνη
- Νταλφοπριστίνη
- Αντοχή
- Γονίδια αντοχής
- Αλυσιδωτή αντίδραση πολυμεράσης
- Staphylococcus
- Linezolid
- Quinupristin
- Dalfopristin
- Resistance
- Resistance genes
- Polymerase chain reaction
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33163